Advantage Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-41
Closed -$1K 999
2018
Q4
$1K Hold
41
﹤0.01% 973
2018
Q3
$1K Sell
41
-1,814
-98% -$42.1K ﹤0.01% 990
2018
Q2
$45K Sell
1,855
-22,374
-92% -$456K 0.03% 386
2018
Q1
$414K Buy
24,229
+781
+3% +$15.2K 0.16% 113
2017
Q4
$444K Buy
23,448
+23,114
+6,920% +$348K 0.14% 118
2017
Q3
$6K Sell
334
-24,745
-99% -$557K ﹤0.01% 797
2017
Q2
$833K Buy
25,079
+2,754
+12% +$85.2K 0.29% 76
2017
Q1
$716K Buy
22,325
+2,248
+11% +$76.7K 0.28% 79
2016
Q4
$728K Buy
20,077
+20,036
+48,868% +$800K 0.27% 75
2016
Q3
$2K Hold
41
﹤0.01% 841
2016
Q2
$2K Hold
41
﹤0.01% 797
2016
Q1
$2K Hold
41
﹤0.01% 787
2015
Q4
$3K Hold
41
﹤0.01% 749
2015
Q3
$2K Hold
41
﹤0.01% 760
2015
Q2
$2K Buy
+41
New +$2.53K ﹤0.01% 795

Other funds holding TEVA